Leucine, a B2B platform, has secured $7 million in its Series A funding round led by Ecoloab. Pravega Ventures, Axilor Ventures, Techstars, and other angel investors also participated.
The startup plans to use these funds to enhance its technology stack and AI capabilities. It aims to expand its reach and serve more customers with this fresh capital.
Leucine, founded in 2019, helps pharmaceutical companies digitize manufacturing workflows using AI. It replaces traditional paper-based compliance procedures with digital solutions, offering insights into the manufacturing process for safer medicines.
Additionally, Leucine has launched its AI framework, Leucine10x, for real-time monitoring and compliance management in pharmaceutical manufacturing, with deployment taking as little as eight weeks.
The startup’s products are in use at over 300 pharmaceutical manufacturing facilities in 10 countries, and its customer base has nearly doubled in the past year.
Leucine, a Chennai-based startup, has recently secured a whopping $7 million in funding for their revolutionary AI-powered platform. This funding will undoubtedly propel them to new heights and pave the way for their future success. Sending our best wishes to the entire Leucine team.
Dr Shishir Gupta founder & CEO of StartupLanes
About us: StartupLanes is an ecosystem for Startups and Investors. Collaborate or find a co-founder, it’s a platform for Entrepreneurs. We love startups! A place for Angel Investors and Venture Capitalists to find investing opportunities in startups. Validate your idea, Learn & Execute.
Startups looking for funding may apply through StartupLanes Funding Application.
Angel Investors Register Free to explore exciting startup investment opportunities.